Back
Nautilus Biotechnology, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
55
NAUT
Nautilus Biotechnology, Inc.
Last Price:
$3.31
Seasonality Move:
-13.38%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and NAUT is experiencing slight buying pressure.
Nautilus Biotechnology, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.64 | Sell |
| 20-day SMA: | 3.04 | Buy |
| 50-day SMA: | 2.61 | Buy |
| 200-day SMA: | 1.57 | Buy |
| 8-day EMA: | 3.33 | Sell |
| 20-day EMA: | 2.43 | Buy |
| 50-day EMA: | 1.32 | Buy |
| 200-day EMA: | 0.39 | Buy |
Nautilus Biotechnology, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.93 | Buy |
| Relative Strength Index (14 RSI): | 55.44 | Buy |
| Chaikin Money Flow: | 42199 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.34 - 3.5) | Buy |
| Bollinger Bands (100): | (1.77 - 2.81) | Buy |
Nautilus Biotechnology, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Nautilus Biotechnology, Inc. Stock
Is Nautilus Biotechnology, Inc. Stock a Buy?
-
Nautilus Biotechnology, Inc. share price is 3.31 while NAUT 8-day simple moving average is 3.64, which is a Sell signal.
-
The stock price of NAUT is 3.31 while Nautilus Biotechnology, Inc. 20-day SMA is 3.04, which makes it a Buy.
-
Nautilus Biotechnology, Inc. 50-day simple moving average is 2.61 while NAUT share price is 3.31, making it a Buy technically.
-
NAUT stock price is 3.31 and Nautilus Biotechnology, Inc. 200-day simple moving average is 1.57, creating a Buy signal.
NAUT Technical Analysis vs Fundamental Analysis
Buy
55
Nautilus Biotechnology, Inc. (NAUT)
is a Buy
Is Nautilus Biotechnology, Inc. a Buy or a Sell?
-
Nautilus Biotechnology, Inc. stock is rated a BuyThe current Nautilus Biotechnology, Inc. [NAUT] share price is $3.31. The Score for NAUT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
Nautilus Biotechnology, Inc. Stock Info
Market Cap:
412.7M
Price in USD:
3.31
Share Volume:
218K
Nautilus Biotechnology, Inc. 52-Week Range
52-Week High:
4.31
52-Week Low:
0.62
Buy
55
Nautilus Biotechnology, Inc. (NAUT)
is a Buy
Nautilus Biotechnology, Inc. Share Price Forecast
-
What is the Nautilus Biotechnology, Inc. stock price today?The Nautilus Biotechnology, Inc. stock price is 3.31 USD today.
-
Will NAUT stock go up or go down?Nautilus Biotechnology, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Nautilus Biotechnology, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Nautilus Biotechnology, Inc. is not overvalued.
Is Nautilus Biotechnology, Inc. Stock a Buy?
-
Nautilus Biotechnology, Inc. share price is 3.31 while NAUT 8-day exponential moving average is 3.33, which is a Sell signal.
-
The stock price of NAUT is 3.31 while Nautilus Biotechnology, Inc. 20-day EMA is 2.43, which makes it a Buy.
-
Nautilus Biotechnology, Inc. 50-day exponential moving average is 1.32 while NAUT share price is 3.31, making it a Buy technically.
-
NAUT stock price is 3.31 and Nautilus Biotechnology, Inc. 200-day simple moving average is 0.39, creating a Buy signal.
Fundamental Analysis of Nautilus Biotechnology, Inc.
Is Nautilus Biotechnology, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Nautilus Biotechnology, Inc.
Should I short Nautilus Biotechnology, Inc. stock?
-
NAUT Moving Average Covergence Divergence (MACD) indicator is 0.93, suggesting Nautilus Biotechnology, Inc. is a Buy
-
Nautilus Biotechnology, Inc. Relative Strength Index (RSI) is 55.44, which suggest Nautilus Biotechnology, Inc. is overbought
-
The Bollinger Bands (25) for Nautilus Biotechnology, Inc. is (2.34 - 3.5), which suggest Nautilus Biotechnology, Inc. is a Buy
-
The Bollinger Bands (100) for Nautilus Biotechnology, Inc. is (1.77 - 2.81), which suggest Nautilus Biotechnology, Inc. is a Buy
* Nautilus Biotechnology, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.